Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • methylation and enhancer qustion

    Hi, thank you for viewing this question. I have a background in biology but not a background in bioinformatics. My question relates to conservation of the positions of enhancers.

    I am looking at the supplementary material of a study that says there are methylations at location 90752569 of chromosome 10, defined as a S_Shore (UCSC_CpG_Islands_Name=chr10:90750293-90751108) of the FAS gene (they mention its the FAS gene according to UCSC_RefGene_Name.) Under the column Enhancer it says "NA".

    However, on Genecard this location is not the location of FAS. Genecard states location of FAS is "chr10:88948601-88954174 (GRCh38/hg38)chr10:90708358-90713931 (GRCh37/hg19))"

    Location 90752569 on chromosome 10 does not seem to fit with FAS but it does with ACTA2 according to Genecard. Genomic Location of ACTA2: chr10:88988929-88997555 (GRCh38/hg38)chr10:90748686-90757312 (GRCh37/hg19)

    What is the meaning of this? Is this a methylation of FAS or ACTA2? Is this an enhancer region? Genecard says FAS has an enhancer for ACTA2. (https://www.genecards.org/cgi-bin/ca....pl?gene=ACTA2) I am grateful for an explanation of this.

Latest Articles

Collapse

  • seqadmin
    The Impact of AI in Genomic Medicine
    by seqadmin



    Artificial intelligence (AI) has evolved from a futuristic vision to a mainstream technology, highlighted by the introduction of tools like OpenAI's ChatGPT and Google's Gemini. In recent years, AI has become increasingly integrated into the field of genomics. This integration has enabled new scientific discoveries while simultaneously raising important ethical questions1. Interviews with two researchers at the center of this intersection provide insightful perspectives into...
    02-26-2024, 02:07 PM
  • seqadmin
    Multiomics Techniques Advancing Disease Research
    by seqadmin


    New and advanced multiomics tools and technologies have opened new avenues of research and markedly enhanced various disciplines such as disease research and precision medicine1. The practice of merging diverse data from various ‘omes increasingly provides a more holistic understanding of biological systems. As Maddison Masaeli, Co-Founder and CEO at Deepcell, aptly noted, “You can't explain biology in its complex form with one modality.”

    A major leap in the field has
    ...
    02-08-2024, 06:33 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 02-28-2024, 06:12 AM
0 responses
21 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-23-2024, 04:11 PM
0 responses
68 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-21-2024, 08:52 AM
0 responses
77 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-20-2024, 08:57 AM
0 responses
67 views
0 likes
Last Post seqadmin  
Working...
X